Simple injection could ease chronic headaches for millions

NCT ID NCT07347730

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting a steroid and numbing medicine into muscle trigger points can relieve chronic cervicogenic headaches (headaches that start from the neck). Over 1,000 adults aged 18-65 with at least 3 months of headaches will receive either the trigger point injection or a nerve block injection. Researchers will track pain, headache frequency, and quality of life for 2 years to see if the simpler injection works just as well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
triamcinolone acetonide and lidocaine injection
What this could lead to
If successful, this could provide a simple, safe injection option for people with chronic cervicogenic headache who haven't found relief from other treatments.
What could go wrong
This is a non-inferiority trial, so it may only show that the injection is as good as, not better than, existing treatments. Long-term benefits and risks are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICOGENIC HEADACHE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myofascial pain syndrome Post-Traumatic Headache

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.